← Nazad


Visser O



Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study. Lancet Oncol. 2017;18(8):1022-39.[Šekerija M]

Autori: Gatta G, Capocaccia R, Botta L, Mallone S, De Angelis R, Ardanaz E, Comber H, Dimitrova N, Leinonen MK, Siesling S, van der Zwan JM, Van Eycken L, Visser O, Žakelj MP, Anderson LA, Bella F, Kaire I, Otter R, Stiller CA, Trama A, RARECAREnet working group
Godina: 2017

Geographical variability in survival of European children with central nervous system tumours. Eur J Cancer. 2017;82:137-48. [Šekerija M]

Autori: Gatta G, Peris-Bonet R, Visser O, Stiller C, Marcos-Gragera R, Sanchez MJ, Lacour B, Kaatsch P, Berrino F, Rutkowski S, Botta L, EUROCARE-5 Working Group
Godina: 2017

The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2). Gynecol Oncol. 2017;144(2):405-13. [Šekerija M]

Autori: Matz M, Coleman MP, Sant M, Chirlaque MD, Visser O, Gore M, Allemani C, the CONCORD Working Group
Godina: 2017

Erratum to “The histology of ovarian cancer: Worldwide distribution and implications for international survival comparisons (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 405-413]. Gynecol Oncol. 2017;147(3):726. [Šekerija M]

Autori: Matz M, Coleman MP, Sant M, Chirlaque MD, Visser O, Gore M, Allemani C, the CONCORD Working Group
Godina: 2017

Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study. Eur J Cancer. 2017;84:335-53. [Šekerija M]

Autori: Minicozzi P, Innos K, Sanchez MJ, Trama A, Walsh PM, Marcos-Gragera R, Dimitrova N, Botta L, Visser O, Rossi S, Tavilla A, Sant M, EUROCARE-5 Working Group
Godina: 2017

(Šekerija M) Survival of adults with primary malignant brain tumours in Europe; Results of the EUROCARE-5 study. European Journal of Cancer. 2015.

Autori: Visser O, Ardanaz E, Botta L, Sant M, Tavilla A, Minicozzi P
Godina: 2015